Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-24

Clinical Trial Update: Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and safety of Combigan versus Timolol added to Xalatan in glaucoma or ocular hypertension; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combigan (brimonidine tartrate and timolol maleate)
  • Xalatan (latanoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-11-24